Featured Research

from universities, journals, and other organizations

People at risk of diabetes offer clues toward novel drugs

Date:
February 14, 2011
Source:
Joslin Diabetes Center
Summary:
Once people develop type 2 diabetes, high blood glucose levels alter their metabolism so much that it becomes difficult to sift through all the clues to find what might enable the disease. By examining people across the spectrum of diabetes -- from healthy to the full-blown disease -- scientists in her lab have found a molecular pathway that offers novel targets for drugs. By examining people across the spectrum of diabetes, scientists in her lab have found a molecular pathway that offers novel targets for drugs.

Once people develop type 2 diabetes, high blood glucose levels alter their metabolism so much that it becomes difficult to sift through all the clues to find what might enable the disease. "To identify factors that play a primary role in disease susceptibility, we want to investigate people before they get to that point," says Mary-Elizabeth Patti, M.D. of Joslin Diabetes Center. By examining people across the spectrum of diabetes -- from healthy to the full-blown disease -- scientists in her lab have found a molecular pathway that offers novel targets for drugs.

People develop type 2 diabetes over time as their bodies become more and more resistant to the hormone insulin, which is necessary to process the glucose in blood that provides energy for cells, explains Dr. Patti, who is also an Assistant Professor at Harvard Medical School.

In research reported online in the Journal of Clinical Investigation on February 14, Joslin clinical researchers, led by Dr. Allison Goldfine, took tiny samples of muscles from three categories of people: some who were healthy, some with a family history of diabetes who showed signs of insulin resistance although their blood glucose levels were normal, and some with full-blown type 2 diabetes.

They found that among the latter two groups, a gene known as STARS was expressed more than twice as much as in healthy people. STARS activates another gene known as SRF, and a group of genes regulated by SRF along with a co-activator protein called MKL1 showed the most increase in expression in the cells of those with type 2 diabetes. When scientists cultivated those cells in vitro, the same results appeared.

Examining the muscles of insulin-resistant mice, the scientists found similar boost in the expression of those key genes.

But was this molecular pathway helping to trigger insulin resistance or just showing up at the scene of the crime?

To find out, the scientists next took muscle cells derived from rodents, reduced the expression of STARS and found that glucose uptake climbed in the cells. They then examined the effect of a chemical that inhibits SRF and found that glucose uptake rates increased in both mice and human cells -- and that the effects were greater in cells from patients who were insulin resistant or had type 2 diabetes. Finally, the investigators showed that giving the chemical inhibitor to mice with high glucose levels also boosted glucose uptake in muscles.

"This pathway holds promise as a target for novel diabetes therapies, and it also gives us tools to understand the pathways of progression to diabetes," concludes Dr. Patti.

Joslin's Wanzhu Jin was lead author on the paper. Co-authors included Allison Goldfine, Tanner Boes, Eun-Young Kim, Merve Emecan, Connor Fitzpatrick, Anish Sen, Ankit Shah, Martha Vokes, Joshua Schroeder, Elizabeth Tatro, and Jose Jimenez-Chillaron of Joslin; Theodore P. Ciaraldi and Robert R. Henry of the Veterans Administration San Diego Healthcare System and University of California/San Diego; and Edward Mun of Brigham and Women's Hospital. Lead funders were the National Institutes of Health and the Graetz Fund.


Story Source:

The above story is based on materials provided by Joslin Diabetes Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wanzhu Jin et al. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. Journal of Clinical Investigation, 2011 DOI: 10.1172/JCI41940

Cite This Page:

Joslin Diabetes Center. "People at risk of diabetes offer clues toward novel drugs." ScienceDaily. ScienceDaily, 14 February 2011. <www.sciencedaily.com/releases/2011/02/110214122639.htm>.
Joslin Diabetes Center. (2011, February 14). People at risk of diabetes offer clues toward novel drugs. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2011/02/110214122639.htm
Joslin Diabetes Center. "People at risk of diabetes offer clues toward novel drugs." ScienceDaily. www.sciencedaily.com/releases/2011/02/110214122639.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Beijing Marathon Runners Brave Hazardous Air Pollution

Beijing Marathon Runners Brave Hazardous Air Pollution

AFP (Oct. 19, 2014) Tens of thousands of runners battled thick smog at the Beijing Marathon on Sunday, with some donning masks as the levels of PM2.5 small pollutant particles soared to 16 times the maximum recommended level. Duration: 00:54 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins